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Abstract 
Background: Chronic Rhinosinusitis (CRS) is a persistent inflammatory disease affecting paranasal sinuses. CRS is 
categorized into two distinct subgroups defined as CRS with nasal polyps (CRSwNP) and CRS without nasal polyps 
(CRSsNP). Although several immune cells are involved in the CRS pathogenesis, the role of T cells is not fully under-
stood. The objective of the present study was to evaluate the frequency of  CD4+ and  CD8+ T cells and macrophages 
in the sinonasal mucosa of CRS patients, as well as to investigate the specific transcription factors for Th1, Th2, Th17, 
and Treg cells.
Methods: In this study, 15 healthy controls, 12 CRSsNP, and 23 CRSwNP patients participated.  CD4+,  CD8+, and 
 CD68+ cells were investigated in the sinonasal tissues using immunohistochemistry. The expression of transcrip-
tion factors related to Th subsets (T-bet, GATA3, Ror-γt, and FoxP3) was evaluated using real-time PCR. Furthermore, 
CRSwNP patients were defined as eosinophilic when eosinophils consisted of more than 10% of total inflammatory 
cells. The Kruskal–Wallis, Mann–Whitney, and Spearman tests were used in statistical analyses.
Results: The median (range) age of the studied groups was: 32 (14–67) for CRSwNP, 28 (10–43) for CRSsNP, and 27 
(17–44) for controls. The number of eosinophils in CRSwNP patients was higher than two other groups, whereas neu-
trophils were elevated in both CRSwNP and CRSsNP groups in comparison to controls. The frequency of  CD4+ and 
 CD8+ T cells, macrophages, and total inflammatory cells were significantly increased in CRSwNP and CRSsNP patients 
compared with controls. The mRNA expression of GATA3 was increased in CRSwNP patients while mRNA expression 
of Ror-γt was elevated in CRSsNP patients. No significant difference was observed in T-bet mRNA expression among 
three groups. Both CRSwNP and CRSsNP patients showed decreased FoxP3 mRNA expression in comparison to 
controls.
Conclusion: The frequency of  CD4+ and  CD8+ T cells was elevated in CRS patients. In addition, we demonstrated 
Th2 dominance in CRSwNP patients and Th17 dominance in CRSsNP patients, implicating different mechanisms may 
underlie the disease. Better CRS classification and targeted therapeutic strategies may be achievable by determining 
the pattern of infiltrating inflammatory cells. Therefore, further experimental investigations on T cells are needed.
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Background
Chronic rhinosinusitis (CRS) is a prevalent disease char-
acterized by persistent inflammation of the paranasal 
sinuses and upper airway tracts for at least 12  weeks. 
With regard to either endoscopic or relevant CT obser-
vations, as well as clinical symptoms, CRS can be cate-
gorized into two distinct groups: CRS with nasal polyps 
(CRSwNP) and CRS without nasal polyps (CRSsNP) [1, 
2]. CRS is associated with a prominent socioeconomic 
burden on public health worldwide. Recently, it is univer-
sally established that inflammatory mechanisms of these 
two subgroups are different [3]. Genetic factors, immune 
system, and nasal microbiome play important roles in 
the CRS development [4]. However, the exact etiology 
of CRS is uncertain and different immunological mecha-
nisms have been described in the CRS pathogenesis [5]. 
Although several therapeutic approaches are suggested 
for CRS management, the disease treatment remains 
challenging [6, 7].
T lymphocytes play major roles in the regulation 
of inflammatory process at mucosal sites [8–10]. The 
remarkable roles of  CD4+ Th (T helper) cells were par-
tially determined in the pathogenesis of CRS. These cells 
consist of IFN-γ+ Th1, IL-4+ Th2, IL-17A+ Th17, and 
 CD4+ regulatory T (Treg) cells [11, 12]. Previous stud-
ies showed that the CRS signature is Th1, Th2, and Th17 
mixture in airway mucosa [8].  CD8+ T cells (cytotoxic or 
 TCTL) are another population of T cells that cytolyze and 
eliminate tumor cells and the cells infected with intracel-
lular pathogens. The occurrence of cytolysis is dependent 
on the perforin and granzyme B secretions to induce cell 
apoptosis in target cells [13]. Similar to  CD4+ Th cells, 
 CD8+ cytotoxic T cells (Tc) can be divided into several 
subsets, including IFN-γ+ Tc1, IL-4+ Tc2, IL-17A+ Tc17, 
and  CD8+ regulatory T (Treg) cells [14, 15]. Previous 
studies that have also noted that Tc2 cells are involved in 
eosinophilic immune responses, whereas Tc1 and Tc17 
cells have been shown to induce neutrophilic immune 
responses in inflammatory sites [15]. It has been demon-
strated that CRSwNP is characterized by predominant 
Th2 responses, whereas CRSsNP is distinguished by ele-
vated Th1 responses [16]. Although the roles of  CD4+ T 
cells are extensively described in CRS, the roles of  CD8+ 
T cells are poorly investigated. Therefore, the aim of the 
present study was to determine the frequency of infiltrat-
ing  CD4+ and  CD8+ T cells and macrophages  (CD68+ 
cells), additionally the mRNA expression of Th cell sub-
sets (T-bet, GATA3, Ror-γt, and FoxP3) in the sinonasal 
mucosa of CRSwNP and CRSsNP patients in comparison 
to healthy controls. We found that the frequency of  CD4+ 
and  CD8+ T cells were significantly elevated in CRS 
patients. In addition, we showed that the expression of 
GATA3 was increased in CRSwNP patients, whereas the 
expression of Ror-γt was elevated in CRSsNP patients. 
Finally, CRS patients indicated lower FoxP3 expression 
than controls.
Patients and methods
Patient selection
Patients suffering from CRS were recruited from the ENT 
and Head and Neck clinic at Hazrat Rasoul Akram Hos-
pital, Iran University of Medical Sciences. Twenty-three 
patients with CRSwNP and 12 patients with CRSsNP 
enrolled in our study. Fifteen inferior turbinate samples 
were collected as controls from subjects undergoing sep-
toplasty due only to nasal septum deviation without a his-
tory of CRS or asthma. The diagnosis of CRS was made 
according to the current European Position Paper on Rhi-
nosinusitis and nasal polyps [17], fulfilling two or more of 
the following criteria: blockage/congestion/obstruction, 
nasal discharge, facial pain/pressure, decrease or loss of 
smell for at least 4 weeks. In addition, CT scan and endo-
scopic scores were recorded to confirm nasal polyp(s). 
Demographic characteristics of population study are 
summarized in Table 1. Lund-Kennedy nasal endoscopy 
scores [18], preoperative Lund-Mackay CT scores [19], as 
well as preoperative and postoperative 22-item Sinonasal 
Outcome Test (SNOT-22) [20], were recorded to calcu-
late clinical scores of each CRS patient. This study was 
approved by the ethics committee of Iran University of 
Medical Sciences (IR.IUMS.REC 1395.95-03-30-27364) 
and all patients filled written informed consent for tis-
sue sample collection. We performed ethical clearance 
according to the ethical standards of the relevant national 
and institutional guidelines on human experimentation 
and with the Helsinki Declaration of 1975, as revised in 
2008. Exclusion criteria are as follow: CRS patients (1) 
with immunodeficiencies, cystic fibrosis, bronchiectasis, 
chronic obstructive pulmonary disease, diabetes melli-
tus, neoplasia, or fungal rhinosinusitis; (2) during preg-
nancy or lactation, and (3) with upper airway infections 
Table 1 Characteristics of controls and CRS patients
VAS visual analogue scales
a Data are expressed as median (IQR)
Controls CRSsNP CRwNP P value
Number 15 12 23
Females/males 5/10 4/8 6/17
Age (year) median 
(min–max)
27 (17–44) 28 (10–43) 32 (14–67) > 0.05
Asthma 0 0 5
CT  scorea 0 7.5 (3–10.75) 19 (14–21) < 0.0001
Endoscopic  scorea 0 1 (0–1) 2 (2–3) < 0.001
VAS  scorea 0 5 (4–7.750) 10 (9–11) < 0.05
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within 1 month ago. All the patients enrolled for surgery 
had previously failed to respond to adequate medical 
treatments. None of the subjects had used systemic or 
nasal corticosteroids, antibiotics, antihistamines, decon-
gestants, and anti-leukotrienes 4  weeks before biopsy/
surgery.
Biopsy and specimens
Tissue samples were divided into three sections; the 
first section was stored at − 80  °C for subsequent RNA 
isolation and the second section was used for protein 
isolation. The last section was fixed overnight for immu-
nohistochemistry in a freshly prepared fixative con-
taining 4% paraformaldehyde in PBS (pH 7.4) and was 
embedded in paraffin wax.
Histological analysis
We used Hematoxylin & Eosin (H&E) staining to evaluate 
the pathologic characteristic of the tissues. To this aim, 
paraffin sections  (5  mm) were stained with H&E. Air-
dried sections were stained with H&E for 60 min at room 
temperature (RT). Then, the stained sections were ana-
lyzed by a pathologist who was blind to the clinical data. 
The number of eosinophils, neutrophils, mononuclear 
cells, total inflammatory cells (eosinophils, neutrophils, T 
cells, macrophages and mononuclear cells), goblet cells, 
and mucosal glands in the lamina propria was counted at 
high power field (HPF) 400×, using an Olympus CX-40 
microscope (Olympus, Tokyo, Japan) and 5 random HPFs 
were selected and observed. Results were presented as 
cells or glands per HPF [8]. CRSwNP patients were cat-
egorized as eosinophilic when eosinophils consisted of 
more than 10% of total inflammatory cells, and as non-
eosinophilic when eosinophils consisted of less than 10% 
of the total inflammatory cells [8].
Immunohistochemistry
CD4 (a marker representing Th cells), CD8 (a marker 
representing  CD8+ T cells), and CD68 (a marker repre-
senting macrophages) were evaluated by immu-nohis-
tochemistry. Sinonasal tissues were dehydrated and 
embedded in the paraffin. Tissue samples were sectioned 
at 3 µm. Then, they were rehydrated through a xylene and 
ethanol series and were immersed in Target Retrieval 
solution (low pH, Dako, Glostrup, Denmark) and auto-
claved at 121 °C for 20 min for the retrieval of antigens. 
Endogenous peroxidase activity was blocked with 3% 
H2O2/methanol. After washing, sections were incubated 
for 30 min in a blocking solution (PBS, pH 7.4, containing 
2% bovine serum albumin [Sigma-Aldrich, Darmstadt, 
Germany], 0.1% Triton X-100, and 0.1% sodium azide) 
at RT to decrease nonspecific bindings [21], then incu-
bated with: Monoclonal Mouse Anti-Human CD4 (1:100, 
Clone 4B12, Dako), Monoclonal Mouse Anti-Human 
CD8 (1:200, Clone C8/144B, Dako), Monoclonal Mouse 
Anti-Human CD68 (1:100, Clone KP1, Dako) for 1  h at 
RT. After the incubation process, all slides were washed 
with Tris-buffered saline (TBS) for 10 min and incubated 
for another 45 min at 30 °C with EnVision™ (Dako), using 
an Autostainer (Dako). The samples were counterstained 
with Mayer’s hematoxylin stain and mounted in Fara-
mount Mounting Medium (Dako), prior to analysis by 
light micros-copy. The number of positive cells in tissue 
sections was counted by a light microscope at a magni-
fication of 400×, using an Olympus CX-40 microscope 
(Olympus, Tokyo, Japan) [22].
Quantitative real‑time polymerase chain reaction
Total RNA was isolated from sinonasal tissues with Tri-
zol (Invitrogen, USA) according to the manufacturer’s 
instructions. RNA integrity and the success of the reverse 
transcription reaction were monitored by PCR amplifica-
tion of glyceraldehyde-3-phosphate dehydrogenase tran-
scripts and denaturing agarose gel 2%. Genomic DNA 
was removed from total RNA, using RNase-free DNase 
Set (Qiagen, Chatsworth, CA, USA). Then, 500 ng of total 
RNA from each sample was utilized to prepare cDNA, 
using PrimeScript™ RT reagent Kit (TaKaRa, Korea). 
Reverse transcription reaction was done in total 20  µL 
of a reaction mixture containing 2.5  U of MML-V (RT; 
GIBCO BRL, Grand Island, NY) and 50 pmol of random 
hexanucleotides at 42  °C for 60  min, followed by 85  °C 
for 5  s to inactivate reverse transcriptase enzyme. Each 
real-time PCR reaction was carried out in a final volume 
of 20  µL, including 10  µL of 2 × SYBR Green Real-time 
PCR Master Mix (TaKaRa, Korea), 1  µL of cDNA, and 
1 µL of the forward and reverse 200 nM primers. Instead 
of cDNA, nuclease-free water was added to each negative 
control microtube. The mRNA expression levels of spe-
cific transcription factors for Th1 (T-bet), Th2 (GATA3), 
Th17 (Ror-γt), and Treg (FoxP3) cells were subsequently 
determined using extracted RNA from tissue biopsies 
using quantitative real-time PCR. The primer sequences 
are listed in Table 2. Real-time PCR was performed using 
Rotor-Gene Q (Qiagen, Hilden, Germany). Conditions 
for 40 cycles of PCR were 95  °C denaturation for 5  s, 
60 °C annealing-extension for 30 Sec. Experiments were 
assayed in duplicate for each sample. The mean thresh-
old cycle values were normalized to beta actin (β-actin) 
expression levels, and the relative mRNA levels of target 
genes were calculated by  2−ΔΔCt method [23, 24].
Statistical analyses
Statistical analyses were carried out with SPSS version 
23.0 (SPSS Inc., Chicago, Illinois, USA) and presented 
using GraphPad Prism software version 6.1 (GraphPad, 
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La Jolla, California). The normality of the data was evalu-
ated by Kolmogorov–Smirnov test. The Kruskal–Wallis 
H test was used to assess significant intergroup varia-
tions. The Mann–Whitney U two-tailed test was used for 
between-group comparisons. The Spearman test was 
used to determine correlations between cellular frequen-
cies. A value of P less than 0.05 was considered statisti-
cally significant.
Results
Comparison of the subject characteristics
In this study, 23 patients (6 females and 17 males) with 
CRSwNP, 12 patients with CRSsNP (4 females and 8 
males), and 15 healthy controls (5 females and 10 males) 
were evaluated. The median (min–max) age of the popu-
lation study was as follows: 32 (14–67) for CRSwNP, 28 
(10–43) for CRSsNP, and 27 (17–44) for controls. We 
also evaluated and compared CT score, endoscopic score, 
and the VAS score in CRS patients, demonstrating sinus 
involvement in comparison to age- and sex-matched 
controls. There was a significant difference between 
CRSwNP and CRSsNP patients in CT score (< 0.0001), 
endoscopic score (< 0.001), and the VAS score (< 0.05). 
Five patients in CRSwNP group had asthma who were 
diagnosed according to the history. Approximately all 
CRSwNP patients with concomitant asthma represented 
high eosinophil infiltration. The demographic and clinical 
characteristics of CRS patients and controls are shown in 
Table 1.
Eosinophils were elevated in CRSwNP patients
In this study, H&E findings showed that CRSwNP group 
was eosinophil dominant (Fig.  1, Table  3) whereas 
CRSsNP group was neutrophil dominant (Fig. 1, Table 3). 
The number of eosinophils was higher in CRSwNP 
patients than CRSsNP patients and controls (CRSwNP 
vs. CRSsNP vs. controls: Pv < 0.0001 for CRSwNP 
vs. controls, Pv = 0.003 for CRSsNP vs. controls, and 
Pv = 0.013 for CRSsNP vs. CRSwNP) (Fig. 2, Table 3). It 
was only observed that the number of eosinophils posi-
tively correlated with the number of total inflammatory 
cells (r = 0.82, Pv < 0.0001), but no relationship was found 
between eosinophils and other cells (Fig.  3). The num-
ber of total inflammatory cells in CRSwNP, CRSsNP, and 
control groups was 91.5 (68.5–129), 42.25 (34–54.5), and 
12.5 (10–20), respectively (Fig.  1, Table  3). According 
to the proportion of eosinophils to the total inflamma-
tory cells, we divided CRSwNP patients into 16 eosino-
philic CRSwNP (ECRS) patients and 7 non-eosinophilic 
CRSwNP (N-ECRS) patients (Table 4).
Neutrophils were elevated in CRSsNP patients
The frequency of infiltrating neutrophils was significantly 
elevated in CRSwNP and CRSsNP groups in compari-
son to controls (Pv = 0.001 and Pv < 0.0001, respectively). 
However, the number of neutrophils was higher in 
CRSsNP group than CRSwNP group (Pv = 0.025) (Fig. 2, 
Table 3). ECRS patients had fewer neutrophils, while the 
N-ECRS patients presented significant neutrophil infil-
tration (Fig. 4, Table 5).
CD4+ T cells were elevated in CRSwNP patients, while  CD8+ 
T cells and macrophages were increased in both CRSwNP 
and CRSsNP groups
CRSwNP group showed enhanced infiltration of  CD4+ T 
cells into the sinonasal mucosa in comparison to CRSsNP 
group and controls (Pv < 0.0001 for CRSwNP vs. controls, 
Pv = 0.016 for CRSsNP vs. controls, and Pv = 0.006 for 
CRSsNP vs. CRSwNP) (Figs.  1 and 2, Table  3). In com-
parison to controls, both CRSwNP and CRSsNP groups 
indicated increased infiltration of  CD8+ T cells into the 
sinonasal mucosa (both groups Pv < 0.0001). Meanwhile, 
there was no significant difference between CRSwNP and 
CRSsNP groups (Figs.  1, and 2, Table  3). Furthermore, 
the number of macrophages was significantly increased 
in CRS patients in comparison to controls (Pv < 0.0001 
for CRSwNP vs. controls, Pv = 0.003 for CRSsNP vs. con-
trols, and Pv = 0.013 for CRSsNP vs. CRSwNP) (Figs.  1 
and 2, Table 3). We also found a significant difference in 
the number of macrophages between ECRS and CRSsNP 
patients (Pv = 0.004) (Fig. 4, Table 5).
GATA3 was increased in CRSwNP patients, Ror‑γt 
was increased in CRSsNP patients, and FoxP3 
was decreased in both groups
It was shown that mRNA expression of GATA3 was 
increased in CRSwNP patients compared with CRSsNP 
and control groups (Pv < 0.0001 for CRSwNP vs. con-
trols, Pv = 0.001 for CRSsNP vs. controls) (Fig.  5). It 
represents Th2 dominance in CRSwNP patients. There 
Table 2 Primer sequences used in real-time PCR
Gene Size (bp) Forward and reverse primers
T-bet 115 F: 5′- CTG GAG GTG TCG GGG AAA C-3′
R: 5′-ATG GGA ACA TCC GCC GTC C-3′
GATA-3 107 F: 5′-TCA TTA AGC CCA AGC GAA GG-3′
R: 5′-GTC CCC ATT GGC ATT CCT C-3′
Ror-γt 144 F: 5′- AGA CTC ATC GCC AAA GCA -3′
R: 5′- CCT TGT AGA GTG GAG GGA AA -3′
FoxP-3 124 F: 5′-ATT CCC AGA GTT CCT CCA CAAC-3′
R: 5′-ATT GAG TGT CCG CTG CTT CTC-3′
β-Actin 131 F: 5′-TCC CTG GAG AAG AGC TAC G-3′
R: 5′-GTA GTT TCG TGG ATG CCA CA-3′
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was no significant difference in T-bet mRNA expres-
sion among three groups (Fig.  5). It was found that 
mRNA expression of Ror-γt was increased in CRSsNP 
patients compared with CRSwNP and control groups 
(Pv = 0.001 for CRSsNP vs. controls and also for 
CRSsNP vs. CRSwNP). No significant difference was 
Fig. 1 The distribution of infiltrating inflammatory cells to the sinonasal tissues. Representative IHC staining of  CD4+ T cells,  CD8+ T cells, and 
 CD68+ macrophages, as well as H&E staining for eosinophils, neutrophils, and total inflammatory cells in controls, CRSsNP, and CRSwNP patients. 
Scale bar 100 µm. CRSsNP chronic rhinosinusitis without polyp, CRSwNP chronic rhinosinusitis with polyp
Table 3 Comparison of Immunohistochemistry and real-time PCR results in controls and CRS patients
NS not significant
Values are expressed as median (IQR). Kruskal–Wallis test was used for unpaired comparisons. Pv < 0.05 was considered statistically significant
Control CRSsNP CRSwNP Control vs 
CRSsNP P value
Control vs 
CRSwNP P value
CRSwNP vs 
CRSsNP P 
value
Eosinophil 0.5 (0.5–1.5) 5.25 (4–7.37) 25 (7–37.5) 0.003 < 0.0001 0.013
Neutrophil 0.5 (0.5–1.5) 8.25 (6.25–10.5) 4 (2.5–6) < 0.0001 0.001 0.014
Total inflammatory cells 12.5 (10–20) 42.25 (34–54.5) 91.5 (68.5–129) 0.004 < 0.0001 0.012
CD4 T cell 1 (1–1) 2 (2–2.75) 4 (3–6) 0.016 < 0.0001 0.006
CD8 T cell 1 (1–1) 6.5 (4.25–8.75) 20 (6–29) < 0.0001 < 0.0001 NS
Macrophage 1 (0–1) 6.5 (5–8) 12 (9–15) 0.003 < 0.0001 0.013
Mononuclear cells 8 (6–13) 13.5 (8.25–19.5) 30 (15–35) NS < 0.0001 0.010
Goblet cells 16.5 (10.5–21.5) 14 (10.25–17.5) 7.70 (5.5–13.5) NS 0.004 0.026
Mucosal glands 22.5 (15.5–35) 19 (15.25–22.75) 14 (7.5–27.5) NS NS NS
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found between CRSwNP and control groups (Fig.  5). 
It demonstrates Th17 dominance in CRSsNP patients. 
In comparison to healthy controls, both CRSwNP 
and CRSsNP groups showed decreased FoxP3 mRNA 
expression (Pv = 0.001 and Pv < 0.0001, respectively). 
There was no significant difference between CRSsNP 
and CRSwNP groups (Fig. 5).
Discussion
Chronic rhinosinusitis (CRS) is an inflammatory condi-
tion affecting the sinonasal mucosa and T lymphocytes 
are important cells in the pathogenesis of CRS [25]. It 
is the first study conducted on the pattern of  CD4+ and 
 CD8+ T cells in Iranian CRS patients. In the current 
study, histological findings revealed that eosinophils 
Fig. 2 The mean numbers of eosinophils, neutrophils,  CD4+ T cells,  CD8+ T cells, macrophages, and total inflammatory cells in controls, CRSsNP, 
and CRSwNP patients. Eosinophils and  CD4+ T cells were elevated in CRSwNP patients and neutrophils in CRSsNP patients.  CD8+ T cells and 
macrophages were increased in both CRSwNP and CRSsNP groups. The Kruskal–Wallis H test was used to assess significant intergroup variability. 
Pv < 0.05 was considered as significant results
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and  CD4+ T cells were elevated in CRSwNP patients. 
While neutrophils were increased in CRSsNP patients. 
On the other hand,  CD8+ T cells and macrophages 
were increased in both CRSwNP and CRSsNP groups. 
In addition, real-time PCR results showed GATA3 was 
increased in CRSwNP patients, Ror-γt was increased in 
CRSsNP patients, and FoxP3 was decreased in CRSwNP 
and CRSsNP patients.
Here we show that the number of  CD4+ cells is elevated 
in CRSwNP patients compared with controls, In consist-
ent with previous studies [8, 22]. However, Cao et  al. 
reported no significant difference between CRSwNP and 
CRSsNP patients as well as ECRS and N-ECRS groups 
[8]. In contrast, Baba et  al. showed that  CD4+ T cells 
were increased in N-ECRS vs. ECRS patients [21].
Although the importance of  CD4+ T cells has been 
widely demonstrated in the pathogenesis of CRS, the 
function of  CD8+ T cells in CRS development is not 
fully determined [26]. Numerous studies reported that 
the infiltration of  CD8+ T cells was increased in nasal 
tissues of CRSwNP patients [8, 26]. Although we show 
that  CD8+ T cells are predominant infiltrating T cells 
in the sinonasal mucosa of CRS patients, we found no 
significant difference between CRS patients. Our study 
also showed that there is no difference in the number of 
 CD8+ T cells between ECRS and N-ECRS groups. How-
ever, a similar study showed that  CD8+ T cell recruit-
ment was significantly increased in adult Chinese CRS 
patients. In spite of our results, there was a significant 
difference between CRSwNP and CRSsNP groups, but 
similarly, they found no significant difference between 
ECRS and N-ECRS patients [8]. Bernstein et al. showed 
that the number of mucosal  CD8+ T lymphocytes was 
increased in the ECRS and N-ECRS groups in compari-
son to the peripheral blood amount that this finding may 
demonstrate the local infiltration of  CD8+ T cells and 
their possible roles in the progression of CRSwNP [27]. 
Another study conducted by Pant et al. showed that the 
percentage of mucosal  CD8+ T cells in CRSwNP patients 
was higher than the peripheral blood of CRSsNP and 
controls [26]. Ma et  al. evaluated the pattern of  CD8+ 
T cell subsets who showed the percentage of Tc2 subset 
was positively correlated with eosinophil count, whereas 
the percentages of Tc1 and Tc17 subsets were positively 
correlated with neutrophil counts in CRSwNP patients 
[28].
Several contradictory explanations may explain higher 
 CD8+ T cells over  CD4+ T cells? 1-Tissue samples were 
collected from different anatomical regions which may 
be different in the pattern and frequency of inflammatory 
cells. Moreover, the simultaneous different Th cell pat-
terns within a single tissue may be observed [9]. 2-Eth-
nical differences and life environment may affect CRS 
development [29]. 3-CD8+ T cells are potentially more 
resistant than  CD4+ T cells against glucocorticoid ther-
apy [8]. 4-Comorbidities such as asthma and atopy may 
play important roles in the severity and the pattern of 
infiltrating cells to the sinonasal tissues [30].
Our findings indicate that the number of macrophages 
is significantly increased in CRS patients. In consist-
ent with our study, Cao et  al. showed that the number 
of  CD68+ cells was significantly higher in CRSwNP than 
CRSsNP patients, however, there was no significant dif-
ference between ECRS and N-ECRS groups [8]. Con-
versely, Van Zele et  al. showed that although there was 
a trend toward a higher number of macrophages in CRS 
patients, no significant difference was detectable [31]. 
However, they didn’t exactly describe  the macrophage 
phenotypes.
The current study shows that the frequency of eosin-
ophils, neutrophils, and total inflammatory cells is 
increased in CRS patients in comparison to controls. Cao 
et  al. reported similar results to our findings. They also 
showed a significant difference between ECRS vs N-ECRS 
and CRSsNP vs ECRS groups [8]. It was well-accepted 
that there is a direct association between eosinophil and 
Fig. 3 Correlation between the number of eosinophils and total 
inflammatory cells in CRSwNP patients. There was a significant 
correlation between eosinophils and total inflammatory cells in 
this group (r = 0.82, Pv < 0.0001). The Spearman test was used to 
determine the correlation
Table 4 Data representing eosinophil counts in CRSwNP 
patients
ECRS eosinophilic chronic rhinosinusitis, N-ECRS non-eosinophilic chronic 
rhinosinusitis
Patient 
group
Number Age 
medians 
(ranges)
Female/
male
Asthma Eosinophil 
counts 
medians 
(IQR)
ECRS 16 35 (24–67) 6/10 5 35 (35–45)
N-ECRS 7 30 (14–38) 0/7 0 6 (5–7)
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neutrophil elevation in the amount of total inflammatory 
cells in CRSwNP and CRSsNP patients, respectively [8, 
32]. We only observed a significant correlation between 
total inflammatory cells and eosinophils in CRSwNP 
patients. This finding is expected because major inflam-
matory cells are eosinophils in CRSwNP patients.
Previous studies have shown that CRSwNP patients 
are characterized by eosinophilic inflammation, Th2 
dominance in western countries whereas Chinese or 
Korean CRSwNP patients are skewed toward neutro-
philic inflammation and enhanced Th1/Th17 cell pat-
tern, while Treg cells were significantly decreased [8, 
29]. It has also been defined that the major characteris-
tic of CRSsNP disease is increased number of Th1 cells 
in the sinonasal mucosa [31]. Our findings indicated 
Fig. 4 The mean numbers of eosinophils, neutrophils,  CD4+ T cells,  CD8+ T cells, macrophages, and total inflammatory cells in ECRS, N-ECRS, and 
CRSsNP groups. The Mann–Whitney U two-tailed test was used for between-group comparisons. ECRS eosinophilic chronic rhinosinusitis, N-ECRS 
non-eosinophilic chronic rhinosinusitis
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that CRSwNP patients were Th2 dominant, while 
CRSsNP patients were Th17 dominant.
As Th2 cells promote eosinophilic inflammation and 
Th17 enhance neutrophilic inflammation; therefore, 
eosinophil recruitment to the sinonasal mucosa can 
contribute to the secretion, synthesis of specific gran-
ules, and release of lipid mediators as well as inflam-
matory cytokines and chemokines [1]. Through these 
inflammatory mediators, eosinophils can promote nasal 
polyp formation and progression. Although ECRS can 
Table 5 Comparison of Immunohistochemistry results in eosinophilic and non-eosinophilic CRSwNP
NS not significant
Values are expressed as median (IQR). Mann–Whitney U test was used for unpaired comparisons. Pv < 0.05 was considered statistically significant
Eosinophilic CRSwNP Non‑eosinophilic 
CRSwNP
Eosinophilic vs Non‑
eosinophilic CRSwNP 
P value
Eosinophilic 
CRSwNP vs CRSsNP 
P value
Non‑eosinophilic 
CRSwNP vs CRSsNP 
P value
Eosinophil 35 (23.13–45) 6 (5–7) 0.011 0.001 NS
Neutrophil 2.75 (1.625–5) 7.5 (5.5–9) NS 0.001 NS
Total inflammatory cells 108.5 (91.5–138) 45.5 (40–77.5) 0.024 0.002 NS
CD4 T cell 4.5 (3–6) 3 (2–6) NS 0.003 NS
CD8 T cell 26 (10–34) 6 (5–13) NS 0.043 NS
Macrophage 14 (11–16.5) 8 (6–11) NS 0.004 NS
Mononuclear cells 30 (15–40.63) 18.5 (8.25–19.5) NS 0.006 NS
Goblet cells 9.25 (5.63–17.25) 7.5 (3.5–9.5) NS NS 0.028
Mucosal glands 13 (7.75–24.5) 22.5 (6–27.5) NS NS NS
Fig. 5 The expression levels of GATA3, T-bet, Ror-γt, and FoxP3 in controls, CRSsNP and CRSwNP patients. GATA3 was increased in CRSwNP 
patients, Ror-γt was increased in CRSsNP patients, and FoxP3 was decreased in CRS patients. No significant difference was reported for T-bet mRNA 
expression among three groups. The Kruskal–Wallis H test was used to assess significant intergroup variations
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be well-controlled via corticosteroid therapy, N-ECRS 
responds to a combination of macrolide therapy and sur-
gical interventions [32].
In contrast, several studies reported that Th2 cells 
were reduced in CRSwNP patients [33, 34], whereas 
Zhang et  al. indicated that there was no significant dif-
ference between CRSwNP and control groups [29]. Th17 
responses are reported to be involved in the pathogen-
esis of multiple inflammatory diseases, including SLE 
and rheumatoid arthritis (RA). Some studies reported 
no significant difference in the number of Th17 cells 
between CRSwNP patients and controls [35, 36]. The 
results of different reports have shown that Th17 cells 
are elevated in CRSwNP patients in East Asian and Chi-
nese populations in comparison to western societies [8, 
37]. Wei et al. suggested a possible role of Th17 cells in 
an adult E-CRS Chinese patients [38]. In line with this 
study, Miljkovic et  al. recently showed the frequency of 
Th17 cells was increased in CRSwNP patients [39]. Con-
versely, we reported that Th17 cells were increased in 
CRSsNP patients which it was the most interesting result 
in our research. This finding is contrary to the previous 
studies which have confirmed that Th1 cells are predomi-
nant T cells in CRSsNP patients [8, 31, 40]. However, the 
exact role of Th17 cells in white CRS patients is not fully 
determined [29, 35]. We propose that it may be associ-
ated with neutrophil accumulation in the sinonasal tis-
sue of CRSsNP patients. Several other explanations for 
these discrepancies may be the ethnical differences, 
disease severity and previous therapeutic interventions 
such as glucocorticoid therapy or antibiotic consump-
tion [33]. However, further investigations are required 
to fully elucidate this new finding. Finally, it is suggested 
to evaluate atopic status in CRSwNP patients and micro-
biological status in both groups, especially CRSsNP 
group. The major limitation of this study is its small 
sample size. Therefore, it is recommended that further 
research is necessary to be undertaken with larger sample 
population.
Conclusion
Although conflicting results are reported on the role 
of T cells in CRS pathogenesis; our study showed that 
frequency of  CD4+ and  CD8+ T cells was increased in 
CRS patients. The findings of this research also pro-
vided insights for Th2 dominance in CRSwNP patients 
and Th17 dominance in CRSsNP patients. This study 
would result in several beneficial clinical outcomes, 
including targeted monoclonal therapies, introduc-
ing novel diagnostic and prognostic biomarkers, and 
reducing unwanted side effects and costs of medical 
treatments. Specific monoclonal antibodies can inhibit 
specific cytokines related to Th2 and Th17 cells in order 
to modulate the inflammatory conditions. Furthermore, 
by determining the miRNAs directing Th polarization 
toward different Th subsets, selected targeting thera-
pies can be achievable. As the Eastern, Middle Eastern, 
Caucasian, and Western populations express heteroge-
neous inflammatory patterns in the composition of Th/
Tc cells, underlying mechanisms in CRS may be differ-
ent and subsequently, more histological investigations 
are needed to completely determine the function and 
the pattern of infiltrating T cells in CRS patients.
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